Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas-Reference-Cited by-同舟云学术

Overexpression of Syk tyrosine kinase in peripheral T-cell lymphomas

Published:2008-04-10 Issue:6 Volume:22 Page:1139-1143
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Feldman A L,Sun D X,Law M E,Novak A J,Attygalle A D,Thorland E C,Fink S R,Vrana J A,Caron B L,Morice W G,Remstein E D,Grogg K L,Kurtin P J,Macon W R,Dogan A

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu200877.pdf

Reference25 articles.

1. Savage KJ, Chhanabhai M, Gascoyne RD, Connors JM . Characterization of peripheral T-cell lymphomas in a single North American institution by the WHO classification. Ann Oncol 2004; 15: 1467–1475.

2. Streubel B, Vinatzer U, Willheim M, Raderer M, Chott A . Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma. Leukemia 2006; 20: 313–318.

3. de Leval L, Savilo E, Longtine J, Ferry JA, Harris NL . Peripheral T-cell lymphoma with follicular involvement and a CD4+/bcl-6+ phenotype. Am J Surg Pathol 2001; 25: 395–400.

4. Pogue SL, Kurosaki T, Bolen J, Herbst R . B cell antigen receptor-induced activation of Akt promotes B cell survival and is dependent on Syk kinase. J Immunol 2000; 165: 1300–1306.

5. Rinaldi A, Kwee I, Taborelli M, Largo C, Uccella S, Martin V et al. Genomic and expression profiling identifies the B-cell associated tyrosine kinase Syk as a possible therapeutic target in mantle cell lymphoma. Br J Haematol 2006; 132: 303–316.

Cited by 123 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Primary intestinal T-cell and natural killer–cell lymphomas: Clinicopathologic and prognostic features of 79 cases in South China;American Journal of Clinical Pathology;2024-08-09

2. SOHO State of the Art Updates and Next Questions | New Pathways and New Targets in PTCL: Staying on Target;Clinical Lymphoma Myeloma and Leukemia;2023-08

3. Tyrosine kinases in nodal peripheral T-cell lymphomas;Frontiers in Oncology;2023-02-08

4. Therapeutic Advances in Relapsed and Refractory Peripheral T-Cell Lymphoma;Cancers;2023-01-18

5. Immunotherapies of retinoblastoma: Effective methods for preserving vision in the future;Frontiers in Oncology;2022-09-05